Patrick I. Borgen, MD

Articles

Dr. Borgen on Common Symptoms of Male Breast Cancer

March 24th 2021

Patrick Borgen, MD, discusses common symptoms of breast cancer in male patients.

Dr. Borgen on the Prognosis of Male Breast Cancer

March 16th 2021

Patrick Borgen, MD, discusses the prognosis of breast cancer in male patients.

Dr. Borgen on Eliminating Opioid Use in Breast Cancer

March 5th 2021

Patrick I. Borgen, MD, discusses eliminating the use of opioids in patients with breast cancer.

COVID-19: The Unexpected Sequelae

May 12th 2020

History will report that the COVID-19 pandemic in Brooklyn, New York peaked on or about April 12, 2020; however, due to the protracted hospitalization experienced by severe COVID-19–positive patients, the heavy in-patient burden continues today.

COVID-19: New York Confirmed Cases Skyrocketing

April 14th 2020

Global COVID-19 cases exceed 1.7 million confirmed cases, and a staggering daily growth rate.

The SARS COVID-19 Pandemic of 2020

April 6th 2020

The SARS COVID-19 virus pandemic came out of nowhere, circling the globe with shocking speed and with a vengeance.

Dr. Borgen on Unanswered Questions With COVID-19

March 19th 2020

Patrick I. Borgen, MD, discusses what is currently known about coronavirus 2019 and unanswered questions that still need to be addressed.

Dr. Borgen on the De-Escalation of Surgery in Breast Cancer

March 8th 2020

Patrick I. Borgen, MD, discusses the trend toward surgical de-escalation in patients with breast cancer.

Dr. Borgen on the Opioid Crisis in Breast Cancer

March 12th 2019

Patrick I. Borgen, MD, chair, Department of Surgery, director, Breast Cancer, Maimonides Medical Center, discusses the opioid crisis related to the treatment of patients with breast cancer.

Turning the Tide on Opioid Prescribing Practices

January 13th 2019

As evidence grows that opioids may potentially worsen oncologic outcomes, surgeons and oncology providers must take an active role in addressing the opioid crisis by adopting similar protocols that decrease the quantity of narcotics available for diversion while ensuring safe patient care.